Evidence map›Paper›PMID 20806431›Full record

ArticleWorld journal of gastroenterology2010

Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids.

Matthew R Bower, Harini S Aiyer, Yan Li, Robert C G Martin

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Curcumin: reclaiming the lost ground against cancer resistance.Cancer drug resistance (Alhambra, Calif.) · 2021
    Review
  4. Article
  5. Review
  6. Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Matthew R BowerDivision of Surgical Oncology, Department of Surgery and James Graham Brown Cancer Center, University of Louisville School of Medicine, 315 East Broadway-Rm 313, Louisville, KY 40202, USA.
Harini S Aiyer
Yan Li
Robert C G Martin
University of Louisville · US

Funding

Prevention of reflux-induced esophageal adenocarcimona by dietary berriesR03CA137801 · NCI · UNIVERSITY OF LOUISVILLE · PI MARTIN, ROBERT C · 2008 to 2009
$148k
NCI NIH HHS 1R03-CA137801NCI NIH HHS R03 CA137801
6 · The paper itself

Abstract

aimTo investigate the ability of curcumin to counteract the impact of bile acids on gene expression of esophageal epithelial cells.

methodsAn esophageal epithelial cell line (HET-1A) was treated with curcumin in the presence of deoxycholic acid. Cell proliferation and viability assays were used to establish an appropriate dose range for curcumin. The combined and individual effects of curcumin and bile acid on cyclooxygenase-2 (COX-2) and superoxide dismutase (SOD-1 and SOD-2) gene expression were also assessed.

resultsCurcumin in a dose range of 10-100 micromol/L displayed minimal inhibition of HET-1A cell viability. Deoxycholic acid at a concentration of 200 micromol/L caused a 2.4-fold increase in COX-2 gene expression compared to vehicle control. The increased expression of COX-2 induced by deoxycholic acid was partially reversed by the addition of curcumin, and curcumin reduced COX-2 expression 3.3- to 1.3-fold. HET-1A cells exposed to bile acid yielded reduced expression of SOD-1 and SOD-2 genes with the exception that high dose deoxycholic acid at 200 mumol/L led to a 3-fold increase in SOD-2 expression. The addition of curcumin treatment partially reversed the bile acid-induced reduction in SOD-1 expression at all concentrations of curcumin tested.

conclusionCurcumin reverses bile acid suppression of gene expression of SOD-1. Curcumin is also able to inhibit bile acid induction of COX-2 gene expression.

Indexed as

ChemopreventionAnti-Inflammatory Agents, Non-SteroidalBile Acids and SaltsCell LineCell ProliferationCell SurvivalCurcuminCyclooxygenase 2Deoxycholic AcidDose-Response Relationship, DrugEpithelial CellsEsophagusGene Expression RegulationHumansSuperoxide DismutaseSuperoxide Dismutase-1Anti-Inflammatory Agents, Non-SteroidalBile Acids and SaltsCurcuminCyclooxygenase 2Deoxycholic AcidSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2

Identifiers

PMID20806431
PMCPMC2932918
OpenAlexW2152345939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.